Advertisement

Loading...

Fresenius SE & Co. KGaA

FSNUFPNK
Healthcare
Medical - Care Facilities
$54.35
$0.00(0.00%)
U.S. Market is Open • 10:12

Fresenius SE & Co. KGaA Fundamental Analysis

Fresenius SE & Co. KGaA (FSNUF) shows weak financial fundamentals with a PE ratio of 20.97, profit margin of 5.53%, and ROE of 6.70%. The company generates $22.9B in annual revenue with weak year-over-year growth of -2.09%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE6.70%
Operating Margin9.80%
PEG Ratio2.34
We analyze FSNUF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 32.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
32.2/100

We analyze FSNUF's fundamental strength across five key dimensions:

Efficiency Score

Weak

FSNUF struggles to generate sufficient returns from assets.

ROA > 10%
3.06%

Valuation Score

Moderate

FSNUF shows balanced valuation metrics.

PE < 25
20.97
PEG Ratio < 2
2.34

Growth Score

Weak

FSNUF faces weak or negative growth trends.

Revenue Growth > 5%
-2.09%
EPS Growth > 10%
1.80%

Financial Health Score

Excellent

FSNUF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.62
Current Ratio > 1
1.32

Profitability Score

Weak

FSNUF struggles to sustain strong margins.

ROE > 15%
6.70%
Net Margin ≥ 15%
5.53%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is FSNUF Expensive or Cheap?

P/E Ratio

FSNUF trades at 20.97 times earnings. This indicates a fair valuation.

20.97

PEG Ratio

When adjusting for growth, FSNUF's PEG of 2.34 indicates potential overvaluation.

2.34

Price to Book

The market values Fresenius SE & Co. KGaA at 1.39 times its book value. This may indicate undervaluation.

1.39

EV/EBITDA

Enterprise value stands at 4.77 times EBITDA. This is generally considered low.

4.77

How Well Does FSNUF Make Money?

Net Profit Margin

For every $100 in sales, Fresenius SE & Co. KGaA keeps $5.53 as profit after all expenses.

5.53%

Operating Margin

Core operations generate 9.80 in profit for every $100 in revenue, before interest and taxes.

9.80%

ROE

Management delivers $6.70 in profit for every $100 of shareholder equity.

6.70%

ROA

Fresenius SE & Co. KGaA generates $3.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.06%

Following the Money - Real Cash Generation

Operating Cash Flow

Fresenius SE & Co. KGaA produces operating cash flow of $2.57B, showing steady but balanced cash generation.

$2.57B

Free Cash Flow

Fresenius SE & Co. KGaA produces free cash flow of $1.17B, offering steady but limited capital for shareholder returns and expansion.

$1.17B

FCF Per Share

Each share generates $2.07 in free cash annually.

$2.07

FCF Yield

FSNUF converts 4.41% of its market value into free cash.

4.41%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

20.97

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.62

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.32

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.07

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How FSNUF Stacks Against Its Sector Peers

MetricFSNUF ValueSector AveragePerformance
P/E Ratio20.9727.91 Better (Cheaper)
ROE6.70%687.00% Weak
Net Margin5.53%-45285.00% (disorted) Weak
Debt/Equity0.620.33 Weak (High Leverage)
Current Ratio1.322795.76 Neutral
ROA3.06%-13557.00% (disorted) Weak

FSNUF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Fresenius SE & Co. KGaA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-39.04%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-75.27%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-43.25%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ